Document is current
Any future updates will be listed below
-
Authors
Tropis, Clémence
Posey, Janna Jernigan
Tansey, Malú Gámez
Heneka, Michael T.
- License Information
-
More Information
Article History
Received: 9 February 2026
Accepted: 25 August 2026
First Online: 5 September 2026
Declarations
Ethical approval: Not applicable.
Competing interests: MTH serves on the science advisory board of the Dementia Discovery Fund, Alector Inc, AndzonBio2, T3D Therapeutics, Muna Therapeutics, CASP-Aid, the Life and Health Sciences Research Institute or the University of Minho School of Medicine, the Lyon Neuroscience Centre, the Cajal Institute, Madrid and the UK Dementia Research Institute at Imperial College London. He has received speaking honoraria from Biogen, Eisai, Sanofi, Merck, Novartis, and Novo Nordisk. MGT is a consultant on NLRP3 for Ventus Pharmaceuticals and F. Hoffmann-La Roche AG. The rest of the authors declare no conflict of interest.
